H-CYTE, INC. - FORM 10-Q - EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - November 17, 2016

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 - H-CYTE, INC.ex31-2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 - H-CYTE, INC.ex31-1.htm
10-Q - FORM 10-Q - H-CYTE, INC.mdvx10q_sept302016.htm
 
EXHIBIT 32
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND 
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER 
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF 
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
  
 
Each of the undersigned, Jarrett Gorlin and Jeffery Wright, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended September 30, 2016, of MedoveX Corp. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: November 17, 2016
 
 
/s/ Jarrett Gorlin
 
Jarrett Gorlin,
 
Chief Executive Officer
 
 
 
 
 
 
 
/s/ Jeffery Wright
 
Jeffery Wright,
 
Chief Financial Officer
 
 

H-CYTE, INC. Reports